We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




High-Throughput Blood-Fractionation System Is Fully Automated

By Labmedica staff writers
Posted on 12 Mar 2008
A high-throughput blood-fractionation system extracts the buffy coat (white blood cells) from whole blood samples as well as separating plasma, serum, and erythrocytes. More...
The innovative, upgradeable system provides a fully automated solution to blood fractionation and processing

Called the automated blood fractionation (ABF) system, it is a self-contained unit capable of processing up to 500 samples per day, providing substantial time and labor cost-savings compared with manual fractionation. In addition, the system eliminates human error, is more reproducible, and facilitates sample tracking and auditing. The unit is also available as a semi-automated system.

The ABF system incorporates vision system technology, which measures the height of each fraction and calculates the volume of each layer following fractionation via centrifugation. It also offers significant health and safety benefits by reducing employee exposure to unscreened blood, and a laboratory information management system (LIMS) interface that ensures ease of acquisition and manipulation of data.

Developed by RTS Life Science (Manchester, UK), the ABF system is planned for launch at the European Spring Biobanking and Biorepositories 2008, scheduled to take place on April 15-16, 2008, in Zurich, Switzerland. Kristian Spreckley, blood-fractionation product manager at RTS Life Science commented, "RTS has developed this new ABF system in response to the unique needs of the biobanking industry. The system should be installed to automate blood fractionation and buffy coat retrieval from whole blood in any high volume environment.”


Related Links:
RTS Life Science

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.